Deutsche Bank AG bought a new stake in Cabot Corporation (NYSE:CBT – Free Report) during the 2nd quarter, Holdings Channel.com reports. The firm bought 55,412 shares of the specialty chemicals company’s stock, valued at approximately $5,033,000.
Other hedge funds have also recently added to or reduced their stakes in the company. Torren Management LLC bought a new stake in shares of Cabot in the 4th quarter valued at $26,000. Rothschild Investment LLC grew its holdings in Cabot by 170.4% during the 4th quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company’s stock worth $27,000 after acquiring an additional 259 shares during the period. Global Retirement Partners LLC raised its position in shares of Cabot by 1,606.9% in the 4th quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock worth $33,000 after acquiring an additional 466 shares in the last quarter. Geneos Wealth Management Inc. lifted its stake in shares of Cabot by 409.0% in the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock valued at $38,000 after purchasing an additional 364 shares during the period. Finally, Danske Bank A S acquired a new position in shares of Cabot in the 3rd quarter valued at about $38,000. Institutional investors own 93.18% of the company’s stock.
Wall Street Analysts Forecast Growth
CBT has been the subject of a number of research analyst reports. Mizuho lifted their target price on Cabot from $80.00 to $90.00 and gave the stock a “neutral” rating in a report on Thursday, June 25th. JPMorgan Chase & Co. raised their price objective on shares of Cabot from $70.00 to $78.00 and gave the stock an “underweight” rating in a research report on Friday, August 7th. UBS Group lowered their price objective on shares of Cabot from $97.00 to $92.00 and set a “neutral” rating for the company in a research note on Wednesday, August 5th. Weiss Ratings reiterated a “hold (c)” rating on shares of Cabot in a research report on Friday. Finally, Wall Street Zen upgraded shares of Cabot from a “hold” rating to a “buy” rating in a report on Sunday, August 9th. Two analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $89.00.
Insider Buying and Selling at Cabot
In related news, CEO Sean D. Keohane sold 91,923 shares of the firm’s stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $86.41, for a total value of $7,943,066.43. Following the completion of the transaction, the chief executive officer directly owned 404,134 shares of the company’s stock, valued at approximately $34,921,218.94. This trade represents a 18.53% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 3.08% of the stock is owned by insiders.
Cabot Price Performance
CBT opened at $83.76 on Wednesday. Cabot Corporation has a 1 year low of $58.33 and a 1 year high of $94.53. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.47 and a quick ratio of 0.97. The company has a market capitalization of $4.32 billion, a price-to-earnings ratio of 23.59, a P/E/G ratio of 10.89 and a beta of 0.84. The firm’s fifty day moving average price is $87.99 and its two-hundred day moving average price is $81.05.
Cabot (NYSE:CBT – Get Free Report) last released its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.66 by $0.01. The company had revenue of $982.00 million during the quarter, compared to analyst estimates of $943.16 million. Cabot had a return on equity of 20.29% and a net margin of 5.23%.Cabot’s quarterly revenue was up 6.4% on a year-over-year basis. During the same period in the prior year, the company posted $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. As a group, analysts anticipate that Cabot Corporation will post 6.37 earnings per share for the current fiscal year.
Cabot Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 28th will be given a dividend of $0.4725 per share. This represents a $1.89 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date is Friday, August 28th. Cabot’s dividend payout ratio (DPR) is currently 53.24%.
About Cabot
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.
The company operates two primary segments: Reinforcement Materials and Performance Materials.
Further Reading
- Five stocks we like better than Cabot
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Corporation (NYSE:CBT – Free Report).
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.
